Agios Pharmaceuticals (AGIO) Total Liabilities: 2012-2025
Historic Total Liabilities for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to $101.4 million.
- Agios Pharmaceuticals' Total Liabilities fell 38.61% to $101.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.4 million, marking a year-over-year decrease of 38.61%. This contributed to the annual value of $122.2 million for FY2024, which is 3.06% down from last year.
- As of Q3 2025, Agios Pharmaceuticals' Total Liabilities stood at $101.4 million, which was down 0.30% from $101.7 million recorded in Q2 2025.
- Agios Pharmaceuticals' Total Liabilities' 5-year high stood at $191.8 million during Q1 2021, with a 5-year trough of $89.0 million in Q1 2025.
- Moreover, its 3-year median value for Total Liabilities was $114.8 million (2023), whereas its average is $116.4 million.
- Per our database at Business Quant, Agios Pharmaceuticals' Total Liabilities crashed by 67.86% in 2021 and then spiked by 37.13% in 2024.
- Quarterly analysis of 5 years shows Agios Pharmaceuticals' Total Liabilities stood at $145.8 million in 2021, then fell by 5.39% to $137.9 million in 2022, then declined by 8.56% to $126.1 million in 2023, then dropped by 3.06% to $122.2 million in 2024, then plummeted by 38.61% to $101.4 million in 2025.
- Its Total Liabilities stands at $101.4 million for Q3 2025, versus $101.7 million for Q2 2025 and $89.0 million for Q1 2025.